Substitution at factor V nucleotide 1691, the Leiden mutation, is the
most common known genetic cause of venous thrombosis, DNA-based assays
for the detection of factor V Leiden alleles follow common strategies
, The Amplify, Interrogate, and Detect strategy includes polymerase ch
ain reaction (PCR) amplification of a factor V gene fragment, interrog
ation with a sequence-specific reagent, such as restriction endonuclea
se or oligonucleotide probe, and detection of the results of interroga
tion, The Differentially Amplify and Detect strategy uses sequence-spe
cific PCR primers to selectively amplify factor V Leiden or normal all
eles, followed by detection of the amplified fragments, Several assays
have been validated in comparison studies and are reliable if perform
ed properly. The choice of assay format depends upon laboratory experi
ence and sample volume.